Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

NCT00423670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

765

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: boceprevir (SCH 503034)
DRUG: peginterferon-alfa 2b (PegIntron)
DRUG: ribavirin
DRUG: ribavirin (low-dose)

Sponsor

Merck Sharp & Dohme LLC